Are you Dr. Pandya?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-328-2567Fax+1 410-328-6896
Summary
- Dr. Naimish Pandya, MD is an oncologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland. He is affiliated with Veterans Affairs Maryland Health Care System-Baltimore Division and University of Maryland Baltimore Washington Medical Center.
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2003 - 2006
- New York Medical College at St Vincent's Hospital and Medical Center of New YorkInternship, Transitional Year, 1998 - 1999
- Lewis Katz School of Medicine at Temple UniversityClass of 1998
Certifications & Licensure
- MD State Medical License 2007 - 2015
Clinical Trials
- A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Untreated, Advanced Non-Small Cell Lung Cancer Start of enrollment: 2010 Dec 16
- A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme Start of enrollment: 2011 Jan 01
- Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma Start of enrollment: 2014 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 39 citationsEvaluation of chemotherapy-induced peripheral neuropathy using current perception threshold and clinical evaluations.Kathleen A. Griffith, Darren J. Couture, Shijun Zhu, Naimish Pandya, Mary E. Johantgen
Supportive Care in Cancer. 2014-05-01 - 16 citationsUse and spending on antineoplastic therapy for Medicare beneficiaries with cancer.Amy J. Davidoff, Thomas Shaffer, Mujde Z. Erten, J S Shoemaker, Ilene H. Zuckerman
Medical Care. 2013-04-01 - 123 citationsA novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomes.Amy J. Davidoff, Ilene H. Zuckerman, Naimish Pandya, Franklin Hendrick, Xuehua Ke
Journal of Geriatric Oncology. 2013-04-01
Press Mentions
- NexImmune Completes Sr. Leadership Team with New VP HiresDecember 4th, 2018